Stroke clinical trials

Explore recruiting stroke clinical trials.

Recruiting stroke studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)

Spain, Germany, Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The DOAC Intravenous Thrombolysis trial

Netherlands, Spain, Germany, Belgium, Austria, Finland +3 more

Therapeutic use (Phase IV) EU CTIS Study details

(20604 OCEANIC STROKE) A multicenter, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA

Slovakia, Latvia, Hungary, Sweden, Netherlands, Austria +14 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab in high-risk patients with Atrial fibrillation who have been deemed unsuitable for oral antiCoagulation (LILAC)

Germany, Czechia, Romania, Bulgaria, Hungary, Poland +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stroke trials by city

Stroke in Toronto Stroke in Vancouver Stroke in Montreal Stroke in Calgary Stroke in Edmonton Stroke in Ottawa Stroke in Winnipeg Stroke in Quebec City Stroke in Hamilton Stroke in Kitchener Stroke in London Stroke in Halifax Stroke in New York Stroke in Los Angeles Stroke in Chicago Stroke in Houston

Stroke clinical trials

Recruiting stroke studies right now

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

Escitalopram and Language Intervention for Subacute Aphasia

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Graded Activity Training and Task- Oriented Training on Post-Stroke Fatigue

Acetyl-leucine in Post-stroke Ataxia

Comperative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation in Subacute Stroke Patients

Impact of VNS With Rehab on Gait Post-Stroke

Sensory Feedback and Hand Motor Adaptation

Acu-TENS to Improve the Sleep Quality in People with Stroke

Improving Stroke Care in North-Norway Through Artificial Intelligence

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Also recruiting in Europe

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)

Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The DOAC Intravenous Thrombolysis trial

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL

Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab in high-risk patients with Atrial fibrillation who have been deemed unsuitable for oral antiCoagulation (LILAC)

Stroke trials by city

Other conditions